[{"AccountsPayableCurrent_0_Q3_USD":4784000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_3_Q3_USD":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_1_Q3_USD":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-85000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":33000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":287000.0,"OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_3_Q3_USD":0.0,"OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_1_Q3_USD":0.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":-8351000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":-15310000.0,"OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent_3_Q3_USD":0.0,"OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent_1_Q3_USD":0.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":8386000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":15564000.0,"OtherAssetsCurrent_0_Q3_USD":3988000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":3907000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.068,"OperatingLeaseRightOfUseAsset_0_Q3_USD":21481000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":23704000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":2267000.0,"OperatingLeaseLiability_0_Q3_USD":25971000.0,"OperatingIncomeLoss_3_Q3_USD":-119382000.0,"OperatingIncomeLoss_1_Q3_USD":-42181000.0,"NetIncomeLoss_3_Q3_USD":-119232000.0,"NetIncomeLoss_1_Q3_USD":-42401000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-123199000.0,"OtherLiabilitiesCurrent_0_Q3_USD":197000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":104291000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":664000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-184000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":129000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":10000.0,"StockholdersEquity_0_Q3_USD":240983000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":0.7,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q3_USD":0.51,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":19891334.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q3_shares":4170230.0,"ShareBasedCompensation_3_Q3_USD":15802000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":4732000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":1203000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-704988000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q3_USD":1717000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":81585000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":28211000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":28689000.0,"ProfitLoss_3_Q3_USD":-119232000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":707000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":190393000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":2529000.0,"PrepaidExpenseCurrent_0_Q3_USD":9970000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":58689000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":4558000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":81363000.0,"PaymentsToAcquireIntangibleAssets_3_Q3_USD":181000.0,"OtherOperatingActivitiesCashFlowStatement_3_Q3_USD":2239000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-237000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":936600648.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":3236000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":353528000.0,"CostsAndExpenses_1_Q3_USD":43384000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":47040000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":6102000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-119282000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-42114000.0,"CommonStockValue_0_Q3_USD":1337000.0,"CommonStockSharesOutstanding_0_Q3_shares":937049820.0,"CommonStockSharesIssued_0_Q3_shares":937049820.0,"CommonStockSharesAuthorized_0_Q3_shares":1240853520.0,"CommonStockParOrStatedValuePerShare_0_Q3_GBP":0.001,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-16849000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":44635000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":42918000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":197202000.0,"AssetsCurrent_0_Q3_USD":300450000.0,"Assets_0_Q3_USD":353528000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q3_USD":0.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":15802000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":5019000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":5019000.0,"AdditionalPaidInCapital_0_Q3_USD":954732000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-10098000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":35087000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":27984000.0,"AccountsReceivableNetCurrent_0_Q3_USD":1641000.0,"CostsAndExpenses_3_Q3_USD":124114000.0,"LiabilitiesCurrent_0_Q3_USD":41137000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_0_Q3_security":0.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.05,"Liabilities_0_Q3_USD":112545000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":7977000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":3932000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":4050000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":3986000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q3_USD":4034000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":978000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q3_USD":16968000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":33948000.0,"InterestIncomeDebtSecuritiesAvailableForSaleOperating_3_Q3_USD":916000.0,"InterestIncomeDebtSecuritiesAvailableForSaleOperating_1_Q3_USD":225000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":1191000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":1696000.0,"IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_3_Q3_USD":-109000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":582000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":208000.0,"IncomeTaxesReceivable_0_Q3_USD":43446000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-118650000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-42193000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":42529000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":15173000.0,"ForeignCurrencyTransactionGainLossUnrealized_3_Q3_USD":213000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":10219000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":-1177000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-0.13,"Depreciation_3_Q3_USD":4333000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":933992708.0,"Ticker":"ADAP","CIK":"1621227","name":"ADAPTIMMUNE THERAPEUTICS PLC","OfficialName":"Adaptimmune Therapeutics plc American Depositary Shares","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"301181409.0","Country":"United Kingdom","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20211104"}]